Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Botanix Pharmaceuticals Limited ( (AU:BOT) ) just unveiled an update.
Botanix Pharmaceuticals Limited has announced the quotation of 257,594 ordinary fully paid securities on the ASX, following the exercise of options or conversion of other convertible securities. This move may enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the availability of its shares for trading.
The most recent analyst rating on (AU:BOT) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Botanix Pharmaceuticals Limited stock, see the AU:BOT Stock Forecast page.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development and commercialization of dermatology and antimicrobial products.
Average Trading Volume: 9,510,310
Technical Sentiment Signal: Sell
Current Market Cap: A$617.7M
See more data about BOT stock on TipRanks’ Stock Analysis page.